Valsartan recalls
Valsartan products have been recalled 27 times, most recently on 2 Jun 2021. The recalling company is usually Aurobindo Pharma USA. The most common reason is nitrosamine impurity.
Total recalls27since 2018
Last 12 months0reported
Class I00% of total
Ongoing17latest 2 Jun 2021
Recalls per month, last 24 months
click a bar for that monthSeverity split
Class I 0 0%Class II 24 89%Class III 3 11%
Why valsartan is recalled
Companies
Product types
By year
Ongoing valsartan recalls
17 active| Reported | Class | Recall | Company | Reason | Where |
|---|---|---|---|---|---|
| Drug | CLASS II | Valsartan Tablets USP 80 mg recalled by Aurobindo Pharma USAValsartan | Aurobindo Pharma USA | Nitrosamine Impurity | Nationwide |
| Drug | CLASS II | Valsartan Tablets USP 320 mg recalled by Aurobindo Pharma USAValsartan | Aurobindo Pharma USA | Nitrosamine Impurity | Nationwide |
| Drug | CLASS II | Valsartan Tablets USP 160 mg recalled by Aurobindo Pharma USAValsartan | Aurobindo Pharma USA | Nitrosamine Impurity | Nationwide |
| Drug | CLASS II | Valsartan Tablets USP 40 mg recalled by Aurobindo Pharma USAValsartan | Aurobindo Pharma USA | Nitrosamine Impurity | Nationwide |
| Drug | CLASS II | Valsartan tablets USP 320 mg recalled by Aurobindo Pharma USAValsartan | Aurobindo Pharma USA | Nitrosamine Impurity | Nationwide |
| Drug | CLASS II | Valsartan Tablets, USP, 80 mg recalled by Mylan PharmaceuticalsValsartan | Mylan Pharmaceuticals | Nitrosamine Impurity | Nationwide |
All valsartan recalls, newest first
27 totalAbout this list
Records come from FDA enforcement reports and USDA FSIS notices, grouped by normalised name. A company operating under several names may appear more than once.